The lipomatosis could be either a direct effect of the PRDM10 variant, for example by gene expression changes other than FLCN reduction, or it may be an adipose tissue-specific effect of folliculin repression and downstream TFE3/TFEB activation, which is described to play a role in adipose tissue (49–52). Here, TFE3 is linked to lipomatosis.